Journals / European Journal of Breast Health / 2022 / Cilt: 18 - Sayı: 3

Mucormycosis of the Breast in a Patient With Breast Carcinoma After COVID-19 Pneumonia

Pages
289–291
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This patient was successfully treated with an aggressive regimen of early surgical debridement along with administration of systemic amphotericin B.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Mucormycosis is a rare, but potentially fatal, fungal infection which is caused by mucormyctes.
📊
Key Findings & Data:Herein, we report the case of a 52 year-old female who was diagnosed with right breast carcinoma in Manipal Hospital, a tertiary cancer care center.
💡
Conclusion & Impact:This patient was successfully treated with an aggressive regimen of early surgical debridement along with administration of systemic amphotericin B.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Mucormycosis is a rare, but potentially fatal, fungal infection which is caused by mucormyctes. These forms of fungi are typically known to infect immunocompromised individuals but are rare in immunocompetent individuals. Herein, we report the case of a 52 year-old female who was diagnosed with right breast carcinoma in Manipal Hospital, a tertiary cancer care center. The patient was a known diabetic and hypertensive and who had recently recovered from coronavirus disease-2019 (COVID-19) pneumonia. In the due course of management, she developed mucormycosis infection at the operative site in her right breast where she had a radiation therapy-induced wound. This patient was successfully treated with an aggressive regimen of early surgical debridement along with administration of systemic amphotericin B.

🔖

Cite This Article

ASHOK, B., RAKSHIT, S., RAUTHAN, A., SOMASHEKHAR, S., JAISWAL, R., KUMAR, R., KARTHIK, H., PRASAD, A., ISLAM, H., ASHWIN, K., FERNANDES, A., SALDAHANA, E. (2022). Mucormycosis of the Breast in a Patient With Breast Carcinoma After COVID-19 Pneumonia. European Journal of Breast Health, Cilt: 18 - Sayı: 3, 289–291. https://ajindex.com/articles/510629

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Dulski TM, DeLong M, Garner K, Patil N, Cima MJ, Rothfeldt L, et al. Notes from the Field: COVID-19-Associated Mucormycosis - Arkansas, July-September 2021. MMWR Morb Mortal Wkly Rep 2021
  2. (PMID: 34914674) [Crossref] 2. Skiada A, Pavleas I, Drogari-Apiranthitou M. Epidemiology and Diagnosis of Mucormycosis: An Update. J Fungi (Basel) 2020
  3. (PMID: 33147877). [Crossref] 3. Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India. Diabetes Metab Syndr 2021
  4. 102146. (PMID: 34192610). [Crossref] 4. Kubin CJ, McConville TH, Dietz D, Zucker J, May M, Nelson B, et al. Characterization of Bacterial and Fungal Infections in Hospitalized Patients With Coronavirus Disease 2019 and Factors Associated With Health Care-Associated Infections. Open Forum Infect Dis 2021
  5. ofab201. (PMID: 34099978). [Crossref] 5. Song G, Liang G, Liu W. Fungal Co-infections Associated with Global COVID-19 Pandemic: A Clinical and Diagnostic Perspective from China. Mycopathologia 2020
  6. (PMID: 32737747). [Crossref] 6. Eucker J, Sezer O, Graf B, Possinger K. Mucormycoses. Mycoses 2001
  7. (PMID: 11714058). [Crossref] 7. Masci JR, Wormser GP. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 6th Edition Edited by Gerald L. Mandell, John E. Bennett, and Raphael Dolin Philadelphia: Elsevier Churchill Livingstone, 2005. 3661 pp., illustrated. $329 (cloth). Clin Infect Dis 2005
  8. [Crossref] 8. Gale GR, Welch AM. Studies of opportunistic fungi. I. Inhibition of Rhizopus oryzae by human serum. Am J Med Sci 1961
  9. (PMID: 13703046). [Crossref] 9. Mahalaxmi I, Jayaramayya K, Venkatesan D, Subramaniam MD, Renu K, Vijayakumar P, et al. Mucormycosis: An opportunistic pathogen during COVID-19. Environ Res 2021
  10. 111643. (PMID: 34237335). [Crossref] 10. Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis 2008
  11. (PMID: 18611163). [Crossref]